Journal · Biotechnology · Updated 21 November 2026
Biotechnology and Bioprocess Engineering
Read Biotechnology and Bioprocess Engineering articles on DeepDyve. No university library needed.
Biotechnology and Bioprocess Engineering has published since 1996 and covers biotechnology from the lab to the bioreactor, from protein purification with magnetic nanoparticles and astaxanthin production in microalgae to nanoparticles for cancer therapy and drug testing on patient tumor samples. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Biotechnology and Bioprocess Engineering at a glance
- Full title
- Biotechnology and Bioprocess Engineering
- Abbreviation (NLM)
- Biotechnol Bioprocess Eng
- Publisher
- Springer Nature
- Print ISSN
- 1226-8372
- Online ISSN (eISSN)
- 1976-3816
- First published
- 1996
- Access model
- Hybrid (15% free to read in 2026)
Ways to access Biotechnology and Bioprocess Engineering
15% of the articles Biotechnology and Bioprocess Engineering published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 15% of Biotechnology and Bioprocess Engineering articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Biotechnology and Bioprocess Engineering. Check its journal list and whether it offers remote access.
- DeepDyve. Read Biotechnology and Bioprocess Engineering articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Biotechnology and Bioprocess Engineering’s 2025 Journal Impact Factor is 2.8, and its 5-year Impact Factor is 2.3.
2.8
Journal Impact Factor (2025)
2.3
5-year Impact Factor (2025)
10 days
Median time to first decision
Source: journal metrics on the Biotechnology and Bioprocess Engineering homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Biotechnology and Bioprocess Engineering research worth reading
Published January to June 2026. Summaries describe what the authors report.
-
Quantitative ex vivo assessment of chemotherapy synergy using patient-derived non-Hodgkin lymphoma samples
Testing tumor biopsies from 31 non-Hodgkin lymphoma patients on CHOP-based regimens, the authors report that ex vivo vincristine sensitivity was the single-agent measure most associated with treatment response, and that pairwise combination sensitivity scores showed stronger associations than single-drug metrics.
Kim et al. · Biotechnology and Bioprocess Engineering, published online January 5, 2026 · DOI 10.1007/s12257-025-00249-z
-
Computational identification of dual-targeting human miRNAs for Zika virus suppression and host pathway restoration
Using a bioinformatics pipeline, the authors identify 15 candidate human miRNAs that may both bind the Zika virus genome and regulate proviral host genes, including hsa-miR-128-3p, previously reported as antiviral, and propose them for future experimental validation.
Dutta et al. · Biotechnology and Bioprocess Engineering, published online April 14, 2026 · DOI 10.1007/s12257-026-00279-1
-
Engineering tumor microenvironment-responsive nanoparticles for targeted cancer therapy
The authors review nanoparticles that release drugs in response to chemical and physical features of the tumor microenvironment, arguing that dual- and multi-responsive designs can help address drug resistance and off-target toxicity, while safety, manufacturing and regulatory challenges remain.
Lee et al. · Biotechnology and Bioprocess Engineering, published online March 5, 2026 · DOI 10.1007/s12257-026-00263-9
-
Purification of recombinant protein using magnetic NiO-decorated Zn ferrite nanoparticles and Ni-Zn ferrite nanoclusters as an alternative to Ni-NTA
The authors report that Ni-Zn ferrite nanoclusters bound more purified protein, but NiO-decorated Zn ferrite nanoparticles recovered more His6-amicyanin from E. coli extracts, and both selectively captured the protein over multiple reuse cycles with a simpler workflow than Ni-NTA.
Yang et al. · Biotechnology and Bioprocess Engineering, published online April 30, 2026 · DOI 10.1007/s12257-026-00282-6
-
Ultrasonic activation of seed cysts enhances photosynthetic astaxanthin production in Haematococcus lacustris
The authors report that a 10-minute ultrasound pretreatment of Haematococcus lacustris cysts improved germination and growth, raising astaxanthin content to 51.7 mg/g dry cell weight and productivity to 7.6 mg/L/d in photobioreactors, increases of 36.9% and 57.4%.
Lakshmi Narasimhan et al. · Biotechnology and Bioprocess Engineering, published online June 2, 2026 · DOI 10.1007/s12257-026-00291-5
See every Biotechnology and Bioprocess Engineering article on DeepDyve
Related journals
Questions about Biotechnology and Bioprocess Engineering
How can I read Biotechnology and Bioprocess Engineering articles without a subscription?
15% of Biotechnology and Bioprocess Engineering articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Biotechnology and Bioprocess Engineering articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Biotechnology and Bioprocess Engineering?
Biotechnology and Bioprocess Engineering’s NLM (PubMed) abbreviation is Biotechnol Bioprocess Eng.
What is the ISSN of Biotechnology and Bioprocess Engineering?
The print ISSN is 1226-8372 and the online ISSN is 1976-3816.
What is the impact factor of Biotechnology and Bioprocess Engineering?
Biotechnology and Bioprocess Engineering’s Journal Impact Factor is 2.8 (2025), and its 5-year Impact Factor is 2.3, according to Springer Nature’s published metrics.
Is Biotechnology and Bioprocess Engineering open access?
Biotechnology and Bioprocess Engineering is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 14 of 92 Biotechnology and Bioprocess Engineering articles (15%) carry a Creative Commons license, per Crossref.
Biotechnology and Bioprocess Engineering articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Biotechnology and Bioprocess Engineering today
One month free, then less than $2 a day. Biotechnology and Bioprocess Engineering, plus millions of articles from thousands of journals.






